Australia markets closed

Seres Therapeutics, Inc. (MCRB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.68-0.75 (-6.56%)
At close: 04:00PM EST
10.99 +0.31 (+2.90%)
After hours: 07:52PM EST
Currency in USD
Earnings estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts9589
Avg. Estimate-0.44-0.55-0.6-1.8
Low estimate-0.62-0.65-0.79-2.6
High estimate-0.03-0.42-0.2-0.76
Year ago EPS-0.23-0.39-1.12-0.6
Revenue estimateCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
No. of analysts8578
Avg. Estimate12.25M4.33M150.99M60.53M
Low estimate3.93M1.25M142.71M20M
High estimate58.3M5.4M196M140M
Year ago sales17.56M6.45M33.22M150.99M
Sales growth (year/est)-30.30%-32.90%354.60%-59.90%
Earnings history30/12/202030/03/202129/06/202129/09/2021
Est. EPS-0.28-0.31-0.37-0.46
Actual EPS-0.23-0.39-0.530.72
Difference0.05-0.08-0.161.18
Surprise %17.90%-25.80%-43.20%256.50%
EPS trendCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Current estimate-0.44-0.55-0.6-1.8
7 days ago-0.49-0.55-0.66-1.93
30 days ago-0.48-0.5-1.86-1.37
60 days ago-0.48-0.5-1.86-1.37
90 days ago-0.48-0.5-1.86-1.36
EPS revisionsCurrent qtr. (Dec 2021)Next qtr. (Mar 2022)Current year (2021)Next year (2022)
Up last 7 days1N/A1N/A
Up last 30 days3161
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/A1
Growth estimatesMCRBIndustrySector(s)S&P 500
Current qtr.-91.30%N/AN/AN/A
Next qtr.-41.00%N/AN/AN/A
Current year46.40%N/AN/AN/A
Next year-200.00%N/AN/AN/A
Next 5 years (per annum)-134.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A